» Articles » PMID: 25281531

Hypercholesterolemia and Its Associated Risk Factors-Kingdom of Saudi Arabia, 2013

Overview
Journal Ann Epidemiol
Publisher Elsevier
Specialty Public Health
Date 2014 Oct 5
PMID 25281531
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To assess the prevalence of hypercholesterolemia and its associated factors in the Kingdom of Saudi Arabia.

Methods: A national multistage representative sample of Saudis aged 15 years or older was surveyed through face-to-face interviews. Data on sociodemographics, risk factors, and health information were collected, and blood sample analysis was performed. Data were analyzed using SAS 9.3 to account for the sample weights and complex survey design.

Results: Between April and June 2013, a total of 10,735 participants completed the survey. Overall, 8.5% of Saudis had hypercholesterolemia. Another 19.6% had borderline hypercholesterolemia. Among hypercholesterolemic Saudis, 65.1% were undiagnosed, 2.3% were treated uncontrolled, 28.3% were treated controlled, and 4.3% were untreated. The risk of being hypercholesterolemic increased with age and among individuals who reported consuming margarine, obese individuals, and those who have been previously diagnosed with hypertension or diabetes.

Conclusions: More than a million Saudis have hypercholesterolemia, and 700,000 of them are unaware of their condition which can be controlled through early detection campaigns and lifestyle change and medication. An urgent awareness and screening campaign is needed in Kingdom of Saudi Arabia to prevent and avoid disease progression toward more serious stages.

Citing Articles

Identifying risk factors and mortality rate of premature coronary artery disease in young Saudi population.

Al-Khlaiwi T, Habib S, Bayoumy N, Al-Khliwi H, Meo S Sci Rep. 2024; 14(1):12727.

PMID: 38830947 PMC: 11148092. DOI: 10.1038/s41598-024-62970-8.


Anthropometrics and Plasma Atherogenic Index in Saudi Women Madinah KSA.

Surrati A, Mohammedsaeed W, Alfadhli E Pak J Med Sci. 2024; 40(3Part-II):364-370.

PMID: 38356847 PMC: 10862441. DOI: 10.12669/pjms.40.3.8318.


The Pandemic of Coronary Heart Disease in the Middle East and North Africa: What Clinicians Need to Know.

Manla Y, Almahmeed W Curr Atheroscler Rep. 2023; 25(9):543-557.

PMID: 37615785 PMC: 10471667. DOI: 10.1007/s11883-023-01126-x.


Magnitude and associated factors of dyslipidemia among patients with severe mental illness in dire Dawa, Ethiopia: neglected public health concern.

Fentie D, Yibabie S BMC Cardiovasc Disord. 2023; 23(1):298.

PMID: 37312056 PMC: 10265782. DOI: 10.1186/s12872-023-03327-3.


2022 Saudi Guidelines for the Management of Dyslipidemia.

AlRahimi J, AlSaif S, Alasnag M, Awan Z, AlMutairi F, Al Mudaiheem H Heart Views. 2023; 24(2):67-92.

PMID: 37305331 PMC: 10249637. DOI: 10.4103/heartviews.heartviews_102_22.